Tandem Diabetes Care, an insulin delivery and diabetes technology company, has bought infusion set developer Capillary Biomedical.
Capillary Biomedical offers unique extended wear infusion set technology currently in development.
“Infusion sets provide people with flexible options in insulin pump wearability, and we are dedicated to expanding our portfolio to offer our customers more choice in personalizing their therapy management system,” said John Sheridan, CEO of Tandem. “Through this acquisition, we look forward to developing new infusion set solutions.”